Effect of gamma irradiation on spleen cell function and cytotoxicity of doxorubicin

Chemico-Biological Interactions

Volumn 173, Issue 3, 2008, Pages 205-214

  Lee, Ju Woon ^a   Sung, Nak Yun ^a   Kim, Jae Kyung ^a   Kim, Jae Hun ^a   Raghavendran, Hanumantha Rao Balaji ^a   Yoo, Yung Choon ^b   Shin, Mee Hye ^c   Byun, Myung Woo ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Konyang University   (South Korea)

^c Eulji University   (South Korea)

Author keywords

Cytokine; Doxorubicin; Gamma irradiation; Heart myoblast; Metastasis; Spleen cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DOXORUBICIN; GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CELL FUNCTION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; GAMMA RADIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG METASTASIS; MALE; MELANOMA; MOUSE; MYOBLAST; NONHUMAN; RAT; SPLEEN CELL; SPLEEN WEIGHT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BODY WEIGHT; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; GAMMA RAYS; INTERFERON TYPE II; INTERLEUKIN-2; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOBLASTS; NEOPLASM TRANSPLANTATION; ORGAN SIZE; SPLEEN;

MUS;

EID: 44349170488     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.03.016     Document Type: Article

References (48)

1. Weiss R.B. The anthracyclines: will we ever find a better doxorubicin. Semin. Oncol. 19 (1992) 670-686
2. Tan C., Tasaka H., Yu K.P., Murphy M.L., and Karnofsky D.A. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 20 (1967) 333-353
3. Blum R., and Carter S. Adriamycin: a new anticancer drug with significant clinical activity. Ann. Intern. Med. 80 (1974) 249-259
4. Richardson D.S., and Johnson S.A. Anthracyclines in haematology: preclinical studies, toxicity and delivery systems. Blood Rev. 11 (1997) 201-223
5. Yi X., Bekeredjian R., DeFilippis N.J., Siddiquee Z., Fernandez E., and Shohet R.V. Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) 1098-1102
6. Gopal N.G.S. Radiation sterilization of pharmaceutical and polymers. Radiat. Phys. Chem. 12 (1978) 35-40
7. Varshney L., and Patel K.M. Effects of ionizing radiation on a pharmaceutical compound, chloramphenicol. Radiat. Phys. Chem. 43 (1994) 471-480
8. Varshney L., and Dodke P.B. Radiation effect studies on anticancer drugs, cyclophosphamide and doxorubicin for radiation sterilization. Radiat. Phys. Chem. 71 (2004) 1103-1111
9. Han D.E., Lee A., Song C.K., Hwang T., Seong H., Lee C.O., and Shin B.C. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int. J. Pharm. 313 (2006) 181-188
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
11. Zhang X.-Y., Li W.-G., Wu Y.-J., Zheng T.-Z., Li W., Qu S.-Y., and Liu N.-F. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int. Immunopharmacol. 5 (2005) 1247-1257
12. Ho C.Y., Lau C.B.S., Kim C.F., Leung K.N., Fung K.P., Tse T.F., Chan H.H.L., and Chow M.S.S. Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. Int. Immunopharmacol. 4 (2004) 1549-1557
13. Freshny I. Culture of Animal Cells: A Manual of Basic Techniques (1983), Alan R Liss, Inc., New York
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol. Methods 65 (1983) 55-63
15. Bachur N.R., Gordon S.L., and Gee M.V. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol. Pharmacol. 13 (1977) 901-910
16. Bachur N.R., Gordon S.L., and Gee M.V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 38 (1978) 1745-1750
17. 2. FEBS Lett. 173 (1984) 27-30
18. Dalloz F., Maingon P., Cottin Y., Briot F., Horiot J.C., and Rochette L. Effects of combined irradiation and doxorubicin treatment: on cardiac function and antioxidant defenses in the rat. Free Radical Biol. Med. 26 (1999) 785-800
19. Wang Z.G., Zhao Z.L., Zhang X.W., and Zhang Y.Y. Analysis of mortal cases caused by dihydroetorphine hydrochloride abuse. Chin. Bull. Drug Depend. 3 (1994) 176-177
20. Miranda C.J., Makui H., Soares R.J., Bilodeau M., Mui J., Vali H., Bertrand R., Andrews N.C., and Santos M.M. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 102 (2003) 2574-2580
21. Wu W.R., Zheng J.W., Li N., Bai H.Q., Zhang K.R., and Li Y. Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice. Eur. J. Pharmacol. 366 (1999) 261-269
22. Wang Y., Gao B., and Tsan M.F. Induction of cytokines by heat shock proteins and concanavalin A in murine splenocytes. Cytokine 32 (2005) 149-154
23. Ferraro C., Quemeneur L., Prigent A.F., Taverne C., Revillard J.P., and Berard N.B. Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res. 60 (2001) 1901-1907
24. Tilquin B. Radio-sterilisation des médicaments. J. Pharm. Belg. 46 (1991) 396-398
25. Boess C., and Bögl K.W. Influence of radiation treatment on pharmaceuticals. A review: alkaloids, morphine derivatives and antibiotics. Drug Dev. Ind. Pharm. 22 (1996) 495-529
26. Tilquin B., and Rollmann B. Recherches à conseiller pour l'application dela sterilisation ionisante des médicaments. J. Chim. Phys. 93 (1996) 224-230
27. O'Garra A., and Murphy K. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5 (1993) 880-886
28. Liblau R.S., Singer S.M., and McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16 (1995) 34-38
29. Mihich E. On the immunomodulating effects of anti-cancer drugs and their therapeutic exploitation. Jpn. J. Clin. Oncol. 30 (2000) 469-471
30. Zhang X.Y., Li W.G., Wu Y.J., Zheng T.Z., Li W., Qu S.Y., and Liu N.F. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int. Immunopharmacol. 5 (2005) 1247-1257
31. Giamila F., Adrian J.P., Matthew W.H., David J.L., and Charles A.D. Interleukin-18 regulation of interferon-γ production and cell proliferation as shown in interleukin-1b-converting enzyme (caspase-1)-deficient mice. Blood 91 (1998) 2118-2125
32. Cohen S.A., Salazar D., and Wicher J. Adriamycin-induced activation of NK activity may initially involve LAF production. Cancer Immunol. Immunther. 15 (1983) 188-193
33. Olson R.D., and Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4 (1990) 3076-3086
34. Richard D.O., Mark B.H., Alma H., Gerald M.W., and Denise G.W. In vitro and in vivo immunosuppressive activity of a novel anthracycline,13-deoxy,5-iminodoxorubicin. Int. Immunopharmcol. 7 (2007) 734-743
35. Fuchs E., and Heusinger H. Ultrasound induced scission of the glycosidic bond in disaccharides. Z. Lebensm Unters. Forsch. 198 (1994) 486-490
36. Ebringerová T.E., Eremeeva O.E., and Khinoverova B.G. Ershov 4-methyl-glucurono-xylan degradation by γ-irradiation. Part 1. Dose effects on the macromolecular properties. Carbohyd. Polym. 15 (1991) 255-263
37. R.J. Woods, A.K. Pikaev (Eds.), Applied Radiation Chemistry, Wiley, New York, 1994, pp. 401-403.
38. Ehrke M.J., Ryoyama K., and Cohen S.A. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture. Cancer Res. 44 (1984) 2497-2504
39. Ikeda H., Old L.J., and Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth F. R. 13 (2002) 95-109
40. Salazar D., and Cohen S.A. Multiple tumoricidal effector mechanisms induced by adriamycin. Cancer Res. 44 (1984) 2561-2566
41. Dix A.R., Brooks W.H., Roszman T.L., and Morford L.A. Immune defects observed in patients with primary malignant brain tumors. J. Neuroimmunol. 100 (1999) 216-232
42. Hadden J.W. Immunodeficiency and cancer: prospects for correction. Int. Immunopharmacol. 3 (2003) 1061-1071
43. Mashino K., Sadanaga N., Tanaka F., Ohta M., Yamaguchi H., and Mori M. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity. Mol. Cancer Ther. 1 (2002) 785-794
44. Agostini F., Bagnasco M., Giunciuglio D., Albini A., De S., and Flora. Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. Int. J. Oncol. 13 (1998) 217-224
45. Olson R.D., Headley M.B., Hodzic A., Walsh G.M., and Wingett D.G. In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin. Int. Immunopharmacol. 7 (2007) 734-743
46. Fuchs E., and Heusinger H. Ultrasound induced scission of the glycosidic bond in disaccharides. Z. Lebensm Unters Forsch. 198 (1994) 486-490
47. Ebringerová T.E., Eremeeva O.E., Khinoverova, and Ershov B.G. 4-methyl-glucurono-xylan degradation by γ-irradiation. Part 1 - Dose effects on the macromolecular properties. Carbohyd. Polym. 15 (1991) 255-263
48. Reid B.D. Gamma processing technology: an alternative technology for terminal sterilization of parenterals PDA. J. Pharm. Sci. Technol. 49 (1995) 83-89